Incidentalome

Gene: TTN

Green List (high evidence)

TTN (titin)
EnsemblGeneIds (GRCh38): ENSG00000155657
EnsemblGeneIds (GRCh37): ENSG00000155657
OMIM: 188840, Gene2Phenotype
TTN is in 15 panels

3 reviews

Dean Phelan (Victorian Clinical Genetics Services)

I don't know

ClinGen gene curation (2017):
The TTN gene has been associated with hypertrophic cardiomyopathy (HCM) in one family with an unusual presentation including variable dilatation, hypertrophy, and trabeculations with some family members meeting criteria for LVNC (Hastings et al, 2016, PMID 27625337). A heterozygous missense variant of unknown significance was reported in affected individuals in this family. Several other variants (missense, splice-site, in frame insertion) have been reported in TTN in patients with HCM. However, upon review, none of these variants were considered to have sufficient evidence to be disease-causing. The mechanism for disease is unknown. Experimental evidence to support the gene-disease association includes its biochemical function as a sarcomere component and protein interaction studies.
In summary, there is limited evidence to support this gene-disease association. Curation Expert Panel on December 14, 2017.

PMID: 28822653 (2017): Our study suggests that TTNtv might be a genetic modifier of HCM and confer an increased risk for cardiovascular death.

PMID: 28223422(2017): suggest oligogenic etiology.

PMID: 28323875 (2017): TTN mutations common in cohort of patients with severe right ventricular hypertrophy.

PMID: 28797094 (2017): deep intronic TTN variants enriched in patients with HCM

PMID: 31628103 (2019): screened HCM cohort (MURF1 binding domain only) and found two missense variants in two unrelated families. Variants segregated with disease (3 affected members of one family, 2 affected members of the other family). Variants are located in the MURF1 binding domain and in vitro functional studies showed increased binding to MURF1 (in vivo studies using zebrafish murf1 mutants show hypertrophic heart and disrupted sarcomeric structure). Suggested to be a novel (dominant negative) mechanism underlying HCM pathogenesis. (note: didn't find variants in GnomAD - quick search)

Summary: Insufficient evidence to support HCM gene-disease association
Created: 29 Jul 2020, 2:32 a.m. | Last Modified: 29 Jul 2020, 2:32 a.m.
Panel Version: 0.89

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

DEFINITIVE by ClinGen for DCM and myopathy.

MODERATE for tibial muscular dystrophy and myofibrillar myopathy.

LIMITED for HCM and ARVC.
Created: 18 May 2021, 3:51 a.m. | Last Modified: 12 Aug 2022, 2:07 a.m.
Panel Version: 0.166

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Cardiomyopathy, dilated, 1G, MIM#604145; Cardiomyopathy, familial hypertrophic, 9, MIM# 613765; Tibial muscular dystrophy, tardive, MIM#600334; Salih myopathy (MIM#611705); Muscular dystrophy, limb-girdle, type 2J, 608807

Publications

Elena Savva (Victorian Clinical Genetics Services)

Green List (high evidence)

NM_001267550.1: predominant in ClinVar and described as the gold standard for describing TTN variants

Unknown significance from missense in DCM

PTC mechanism - Likely dominant negative as not all truncated transcripts in DCM undergo NMD (RNAseq and protein studies by Roberts, AM. et al. (2015)).

Incomplete penetrance of PTC variants in DCM
Created: 29 Mar 2020, 8:46 p.m. | Last Modified: 29 Mar 2020, 8:46 p.m.
Panel Version: 0.22

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Cardiomyopathy, dilated, 1G, 604145; Cardiomyopathy, familial hypertrophic, 9, 613765; Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807; (LGMDR10); Myopathy, myofibrillar, 9, with early respiratory failure, 603689; Salih myopathy, 611705; Tibial muscular dystrophy, tardive, 600334

Publications

History Filter Activity

12 Aug 2022, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: ttn has been classified as Green List (High Evidence).

12 Aug 2022, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: TTN were set to

12 Aug 2022, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: TTN was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal

12 Aug 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag cardiac tag was added to gene: TTN.

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: TTN was added gene: TTN was added to Incidentalome_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: TTN was set to Unknown